By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Contact Information

Website: www.ardelyx.com
Email: kkeshtbod@ardelyx.com
Main Phone: +1 510 745-1700
Address: 34175 Ardenwood Boulrvard
Address 2: Suite 200
State: CA
City / Town: Fremont
Country: US
Postal Code: 94555

Issuer Information

Exchange: NSD
CEO: Michael G. Raab
Employees: 129
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A